Russian deal with Oxford vaccine still extant?  July 2020? 

‘Russian drugmaker R-Pharm has signed a licensing deal with Britain's AstraZeneca to produce and distribute doses of its University of Oxford-partnered adenovirus-based COVID-19 shot, AZD1222.’

https://t.co/EP8DDehCAy